Novartis AG (LTS:0K9E)
$ 104.7 0 (0%) Market Cap: 209.81 Bil Enterprise Value: 227.95 Bil PE Ratio: 12.53 PB Ratio: 5.07 GF Score: 80/100

Novartis AG ESG Investor Event Transcript

Sep 09, 2019 / 11:30AM GMT
Unidentified Company Representative

It is my pleasure and honor to introduce kind of Novartis ESG team and also Vas today. But before I pass it over to Samir to introduce the rest (inaudible) call, we're very pleased to have Vas, the CEO of Novartis [Pharma] today. In terms of the format we're going to have (inaudible) for the first half of the presentation and then go to Q&A after that. Other speakers today also include Klaus Moosmayer, who is the Chief Ethics, Risk and Compliance Officer; and Patrice Matchaba, who is the Group Head of Global Health and Corporate Responsibility. We've got additional Novartis speakers are also available for Q&A part of the session. So with that, I'm going to pass it over to Samir.

Samir Shah
Novartis AG - Global Head of IR

Okay. So...

(technical difficulty)

(inaudible) very slow here inside, so -- but also for the webcast. I think the webcast, I'm afraid I'll have -- you might need to read through the safe harbor statement. So the information presented today contains forward-looking statements that involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot